Patent application number | Description | Published |
20100271952 | METHOD OF MEASUREMENT REPORTING AND CELLULAR RADIO TERMINAL - A method of measurement reporting and a cellular radio terminal are provided. A method of measurement reporting comprises receiving, while a measurement reporting scheme is active, a request for a radio connection reconfiguration, suspending the measurement reporting scheme upon the receiving a request and resuming the suspended measurement reporting scheme upon a completion of the radio connection reconfiguration. A cellular radio terminal is configured to carry out the method of measurement reporting. | 10-28-2010 |
20100273472 | METHOD OF MEASUREMENT REPORTING, METHOD OF HANDLING MEASUREMENT REPORTS, CELLULAR RADIO TERMINAL AND CELLULAR RADIO NETWORK UNIT - A method of measurement reporting, a method of handling measurement reports, a cellular radio terminal and a cellular radio network unit are provided. A method of measurement reporting comprises sending a first measurement report and sending a second measurement report after the sending a first measurement report, the second measurement report comprising an indication that the first measurement report is not valid anymore. A method of handling measurement reports comprises receiving such first and second measurement reports, discarding the first measurement report and processing the second measurement report. A cellular radio terminal is configured to carry out the method of measurement reporting. A cellular radio network unit is configured to carry out the method of handling measurement reports. | 10-28-2010 |
20120120898 | METHOD OF MEASUREMENT REPORTING AND CELLULAR RADIO TERMINAL - A method of measurement reporting and a cellular radio terminal are provided. A method of measurement reporting comprises receiving, while a measurement reporting scheme is active, a request for a radio connection reconfiguration, suspending the measurement reporting scheme upon the receiving a request and resuming the suspended measurement reporting scheme upon a completion of the radio connection reconfiguration. A cellular radio terminal is configured to carry out the method of measurement reporting. | 05-17-2012 |
20140128083 | CELL TRANSFER CONTROLLER AND METHOD FOR SELECTING A RADIO CELL - A cell transfer controller is described comprising a detector configured to detect radio cells available for a mobile terminal; a determiner configured to determine, for a first radio cell detected by the detector, a waiting period after which the radio cell is selectable by the cell transfer controller as a target cell for a cell transfer and a controller, configured to increase the length of the waiting period in case that during the waiting period, the detector detects a second radio cell which fulfills a predetermined criterion. | 05-08-2014 |
20140242987 | RADIO COMMUNICATION DEVICES AND METHODS FOR CONTROLLING A RADIO COMMUNICATION DEVICE - A radio communication device may be provided. The radio communication device may include: a measurement circuit configured to measure a reception quality of a signal from a second radio communication device; a memory configured to store signal information indicating the reception quality of the signal measured by the measurement circuit; a configuration information receiver configured to receive configuration information for the radio communication device based on the measured reception quality; a quality indication determination circuit configured to determine a quality indication of a communication with the second radio communication device based on the stored signal information and the received configuration information; and a connection establishing determination circuit configured to determine whether to establish a connection for communication with the second radio communication device based on the determined quality indication. | 08-28-2014 |
Patent application number | Description | Published |
20100130455 | BISMETHYLENE-17A CARBOLACTONES AND RELATED USES - Described herein are bismethylene-17α carbolactone derivatives having progestational and/or antimineralocorticoid and/or aldosterone antagonistic activity. Also described herein are methods of preparing and using these novel compounds. | 05-27-2010 |
20100137264 | PROGESTATIONAL 3-(6,6-ETHYLENE-17B-HYDROXY-3-OXO-17A-PREGNA-4-ENE-17A-YL)PROPIONIC ACID G-LACTONES - Described herein are 3-(6,6-ethylene-17β-hydroxy-3-oxo-17α-pregna-4-ene-17α-yl)propionic acid γ-lactone derivatives having progestational and aldosterone antagonistic activity. Also described herein are methods of preparing and using these novel compounds. | 06-03-2010 |
20100261896 | METHODS FOR THE PREPARATION OF DROSPIRENONE - Described herein are methods of making drospirenone. Also described are intermediate compounds that may be used to synthesis drospirenone. | 10-14-2010 |
20100273759 | PROGESTERONE ANTAGONISTS - Described herein are compounds which exhibit progesterone antagonistic effects and methods of treating cancer using such compounds. | 10-28-2010 |
20110236462 | INTRAVAGINAL DRUG DELIVERY DEVICE - Described herein is an intravaginal drug delivery system. In an embodiment the intravaginal drug delivery system includes a progestin and estrogen compound, and releases the active ingredients in a fixed physiological ratio over a prolonged period of time to produce a contraceptive state in a female. | 09-29-2011 |
20110250274 | ESTRIOL FORMULATIONS - Disclosed herein are oral dosage forms and methods of their use, in particular oral dosage systems for the delivery of estriol compounds. Embodiments described herein relate to rapidly disintegrating oral dosage formulations that disintegrate in the saliva of the buccal and/or sublingual and/or esophageal cavity. Oral dosage forms described herein relate to stabilized amorphous and nanocrystalline forms of the active ingredients of the formulations. | 10-13-2011 |
20130029953 | PROGESTERONE ANTAGONISTS - Described herein are compounds which either act as pure antiprogestins or as antiprogestins with partial agonistic activity and methods of treating cancer using such compounds. | 01-31-2013 |
20130123523 | METHODS FOR THE PREPARATION OF ETONOGESTREL AND DESOGESTREL - Described herein is a process for the synthesis of etonogestrel and desogestrel and intermediates used to form etonogestrel and desogestrel. | 05-16-2013 |
20140364600 | IMIDAZOLYL PROGESTERONE ANTAGONISTS - Described herein are imidazolyl compounds which either act as pure antiprogestins and methods of using such pure antagonists for gynecological indications and breast cancer. | 12-11-2014 |
20150018322 | PRO-DRUG FORMING COMPOUNDS - Various prodrug compounds having the general structure: Active agent-(acid)-(linker)-SO | 01-15-2015 |